These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7430335)

  • 1. Autobac I procedure to assess susceptibility to Cefaclor.
    Gröschel D; Mills K; Hopfer RL
    J Clin Microbiol; 1980 Jun; 11(6):660-3. PubMed ID: 7430335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Larsson P; Lincoln K; Lind L; Sandberg T
    Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Infection; 1979; 7 Suppl 6():557-61. PubMed ID: 45088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.
    Jones RN; Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1979 Oct; 72(4):578-85. PubMed ID: 495560
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.
    Preston DA; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1983 Jun; 17(6):1156-8. PubMed ID: 6874906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.
    Levison ME; Santoro J; Agarwal BN
    Postgrad Med J; 1979; 55 Suppl 4():12-6. PubMed ID: 548939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections.
    Dillon HC; Gray BM; Ware JC
    Postgrad Med J; 1979; 55 Suppl 4():77-81. PubMed ID: 548944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of the disc sensitivity test for cefaclor].
    Kanazawa Y; Kuramata T; Matsumoto K
    Jpn J Antibiot; 1983 Apr; 36(4):717-24. PubMed ID: 6348334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae.
    Powell M; Williams JD
    J Antimicrob Chemother; 1988 Jan; 21(1):27-31. PubMed ID: 3258594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteriological in vitro investigations with cefaclor. Correlation of inhibition zone diameter and minimal inhibitory concentration (author's transl)].
    Grimm H
    Infection; 1979; 7 Suppl 6():540-2. PubMed ID: 399245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
    Shelton MM; Welch DF
    Chemotherapy; 1989; 35(2):88-94. PubMed ID: 2788068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies with cefaclor, a new oral cephalosporin.
    Sanders C
    Antimicrob Agents Chemother; 1977 Oct; 12(4):490-7. PubMed ID: 921244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion disk susceptibility testing with cefaclor.
    Shadomy S; Carver M
    Antimicrob Agents Chemother; 1978 Feb; 13(2):228-33. PubMed ID: 646345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance of gram-negative bacteria against cefaclor and other antibiotics (author's transl)].
    Schassan HH
    Infection; 1979; 7 Suppl 6():527-31. PubMed ID: 399243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro microbiological activity and stability of cefaclor.
    Gillett AP; Andrews JM; Wise R
    Postgrad Med J; 1979; 55 Suppl 4():9-11. PubMed ID: 44910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Haemophilus influenzae type b to cefaclor and influence of inoculum size.
    Levin RM; Azimi PH; Dunphy MG
    Antimicrob Agents Chemother; 1982 Nov; 22(5):923-5. PubMed ID: 6983863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C
    Infection; 1987; 15(2):122-4. PubMed ID: 3596808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.